NRx Pharmaceuticals, Inc. NRXP

Set alert

Price alert · NRXP

All alert types
2.27 USD -0.39 -14.66%

At close · Oct 30

2.21 -0.06 -2.64%

After hours · Oct 30, 7:59 PM ET

Bid
2.26 × 2
Ask
2.27 × 2
2.11 Day range 2.83
1.68 52-week range 4.62
YTD
-16.24%
1 year
-24.83%
Open
2.83
Prev close
2.66
Mkt cap
98.28M
Vol
15.64M
Avg vol
856.32K
EPS
-0.58
P/E
0.00
Div yield
0.00%
More statistics
Low
2.11
High
2.83
Forward P/E
-1.12
Beta
1.27
Short ratio
4.80
Inst. own
6.05%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
1.28
200-d avg
2.53
1y target
31.67

5D chart

Chart tools
Interval

Signals (57)
NameTimeAgo
SMA: BearishOct 30, 3:20 PM1 day ago
SMA: BearishOct 30, 2:00 PM1 day ago
SMA: BullishOct 30, 1:00 PM1 day ago
SMA: BullishOct 30, 1:00 PM1 day ago
SMA: BearishOct 30, 12:40 PM1 day ago
SMA: BullishOct 30, 12:10 PM1 day ago
RSI: OversoldOct 30, 11:40 AM1 day ago
SMA: BearishOct 30, 10:50 AM1 day ago
MACD: Buy SignalOct 30, 10:45 AM1 day ago
SMA: BullishOct 30, 10:30 AM1 day ago
RSI: OversoldOct 30, 9:55 AM1 day ago
MACD: Sell SignalOct 30, 9:35 AM1 day ago
SMA: BearishOct 30, 9:30 AM1 day ago
RSI: OversoldOct 30, 9:30 AM1 day ago
SMA: BullishOct 29, 3:30 PM2 days ago
MACD: Buy SignalOct 29, 3:30 PM2 days ago
SMA: BearishOct 29, 2:25 PM2 days ago
MACD: Sell SignalOct 29, 2:25 PM2 days ago
MACD: Buy SignalOct 29, 2:20 PM2 days ago
RSI: OversoldOct 29, 1:15 PM2 days ago
SMA: BearishOct 29, 12:00 PM2 days ago
MACD: Sell SignalOct 29, 10:40 AM2 days ago
SMA: BearishOct 29, 10:35 AM2 days ago
SMA: BearishOct 29, 10:10 AM2 days ago
RSI: OverboughtOct 29, 9:30 AM2 days ago
SMA: BullishOct 28, 3:40 PM3 days ago
MACD: Buy SignalOct 28, 3:30 PM3 days ago
SMA: BullishOct 28, 12:50 PM3 days ago
SMA: BearishOct 28, 12:45 PM3 days ago
MACD: Sell SignalOct 28, 12:45 PM3 days ago
MACD: Buy SignalOct 28, 12:05 PM3 days ago
MACD: Sell SignalOct 28, 11:55 AM3 days ago
MACD: Buy SignalOct 28, 11:45 AM3 days ago
SMA: BullishOct 28, 11:40 AM3 days ago
SMA: BullishOct 28, 11:40 AM3 days ago
SMA: BearishOct 28, 11:30 AM3 days ago
SMA: BearishOct 28, 11:30 AM3 days ago
SMA: BearishOct 28, 10:35 AM3 days ago
MACD: Sell SignalOct 28, 10:10 AM3 days ago
SMA: BearishOct 28, 10:00 AM3 days ago
MACD: Buy SignalOct 28, 9:30 AM3 days ago
SMA: BullishOct 27, 3:55 PM4 days ago
SMA: BullishOct 27, 3:55 PM4 days ago
SMA: BearishOct 27, 3:20 PM4 days ago
MACD: Sell SignalOct 27, 3:20 PM4 days ago
MACD: Buy SignalOct 27, 3:15 PM4 days ago
MACD: Sell SignalOct 27, 3:10 PM4 days ago
MACD: Buy SignalOct 27, 2:50 PM4 days ago
MACD: Sell SignalOct 27, 2:45 PM4 days ago
MACD: Buy SignalOct 27, 1:45 PM4 days ago
SMA: BullishOct 27, 1:20 PM4 days ago
SMA: BearishOct 27, 12:40 PM4 days ago
MACD: Sell SignalOct 27, 11:25 AM4 days ago
RSI: OverboughtOct 27, 10:10 AM4 days ago
MACD: Buy SignalOct 26, 1:10 PM5 days ago
SMA: BearishOct 26, 11:10 AM5 days ago
RSI: OverboughtOct 26, 10:50 AM5 days ago

Financial health

Altman Z-Score

-13.82 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.0×
FY 2017: -807×FY 2018: 1377×FY 2019: 133×FY 2020: -162×FY 2021: -6.4×FY 2022: -18.5×FY 2023: -1.2×FY 2024: -0.9×FY 2025: -2.0×
FY 2017 5y median -2.0× FY 2025
P/S 47.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 47.3×
FY 2017 5y median 0.0× FY 2025
P/B -3.6×
FY 2017: 1.3×FY 2018: 1.3×FY 2019: 1.8×FY 2020: -3.0×FY 2021: 108×FY 2022: 98.5×FY 2023: -3.0×FY 2024: -1.0×FY 2025: -3.6×
FY 2017 5y median -1.0× FY 2025
P/FCF -4.1×
FY 2017: -644×FY 2018: -192×FY 2019: -68.0×FY 2020: -58.8×FY 2021: -59.5×FY 2022: -18.4×FY 2023: -1.6×FY 2024: -2.2×FY 2025: -4.1×
FY 2017 5y median -4.1× FY 2025
EV/EBITDA -1.8×
FY 2017: -829×FY 2018: 1113×FY 2019: 113×FY 2020: -2.6×FY 2021: -23.8×FY 2022: -18.1×FY 2023: -1.3×FY 2024: -1.2×FY 2025: -1.8×
FY 2017 5y median -1.8× FY 2025
EV/Sales 41.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 41.5×
FY 2017 5y median 0.0× FY 2025
FCF Yield -24.3%
FY 2017: -0.2%FY 2018: -0.5%FY 2019: -1.5%FY 2020: -1.7%FY 2021: -1.7%FY 2022: -5.4%FY 2023: -62.2%FY 2024: -46.0%FY 2025: -24.3%
FY 2017 5y median -24.3% FY 2025

Profitability

Gross Margin 58.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 58.8%
FY 2017 5y median 0.0% FY 2025
Operating Margin -1324.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -1324.4%
FY 2017 5y median 0.0% FY 2025
Net Margin -2336.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -2336.5%
FY 2017 5y median 0.0% FY 2025
ROE 179.6%
FY 2017: -0.2%FY 2018: 0.1%FY 2019: 1.4%FY 2020: 118.3%FY 2021: -447.3%FY 2022: -536.6%FY 2023: 257.0%FY 2024: 108.2%FY 2025: 179.6%
FY 2017 5y median 108.2% FY 2025
ROIC 106.0%
FY 2017: 0.0%FY 2018: -1.1%FY 2019: -1.9%FY 2020: 51.3%FY 2021: -446.5%FY 2022: -247.2%FY 2023: 1072.6%FY 2024: 118.4%FY 2025: 106.0%
FY 2017 5y median 106.0% FY 2025
ROA -220.9%
FY 2017: -0.2%FY 2018: 0.1%FY 2019: 1.3%FY 2020: -1760.5%FY 2021: -284.3%FY 2022: -154.0%FY 2023: -412.2%FY 2024: -688.2%FY 2025: -220.9%
FY 2017 5y median -284.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 17.7%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 29.1%FY 2020: -2993.3%FY 2021: -331.5%FY 2022: 53.4%FY 2023: 37.8%FY 2024: 28.6%FY 2025: 17.7%
FY 2017 FY 2025
EPS (diluted) 43.9%
FY 2017: 0.0%FY 2018: 161.8%FY 2019: 979.6%FY 2020: -288.8%FY 2021: -392.7%FY 2022: 91.9%FY 2023: -563.3%FY 2024: 39.9%FY 2025: 43.9%
FY 2017 FY 2025
Free Cash Flow -32.7%
FY 2017: 0.0%FY 2018: -248.4%FY 2019: -67.5%FY 2020: -186.0%FY 2021: -1563.4%FY 2022: -5.4%FY 2023: 45.5%FY 2024: 50.9%FY 2025: -32.7%
FY 2017 FY 2025

Financial Health

Current Ratio 0.3×
FY 2017: 5.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Quick Ratio 0.3×
FY 2017: 5.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Debt / Equity -0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 1.4×FY 2023: -0.8×FY 2024: -0.3×FY 2025: -0.0×
FY 2017 5y median -0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 4.3×FY 2018: 8.2×FY 2019: 4.0×FY 2020: 0.0×FY 2021: 0.3×FY 2022: 0.2×FY 2023: -0.2×FY 2024: -0.2×FY 2025: 0.3×
FY 2017 5y median 0.2× FY 2025
Interest Coverage -24.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -394×FY 2021: -5289×FY 2022: 0.0×FY 2023: -230×FY 2024: -18.3×FY 2025: -24.2×
FY 2017 5y median -24.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31